Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.51) by 9.8 percent. This is a 2.13 percent increase over losses of $(0.47) per share from the same period last year.
DZS Collaborates With Major Global 5G Carriers And Ecosystem Partners At O-RAN ALLIANCE PlugFests Worldwide To Validate Standards And Use Cases
DZS (NASDAQ:DZSI), a global leader in access and optical edge networking infrastructure and cloud edge software solutions, today announced its participation in three O-RAN ALLIANCE Global PlugFest Fall
